Dr. Andrei Miclea is an Investment Analyst in the Life Sciences team. Previously, he was a strategy consultant in the Pharma & Life Sciences team of Strategy& (formerly Booz & Co) in Zurich. He holds a doctorate in medicine with several years of medical experience in the neurology department at the University Hospital of Bern and a research focus in the field of neuroimmunology. He completed his postdoctoral fellowship in translational multiple sclerosis research at Harvard Medical School / Brigham and Women’s Hospital as a fellow of the Swiss National Science Foundation. He completed his medical studies at the Charité – Universitätsmedizin Berlin.